Drug combination sidesteps resistance in aggressive childhood neuroblastoma models

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that currently claims 9 out of 10 young patients who experience recurrence. The team at the Garvan Institute of Medical Research in…

Continue Reading

News Source: medicalxpress.com